Rocket Lab: From Sell To Strong Buy After The Iridium Acquisition

Rocket Lab (RKLB) announced an $8B acquisition of Iridium, completing its three-pillar strategy (launch, space systems, and space-based connectivity). The deal adds 2.5M subscribers, global L-band spectrum, and 66 LEO satellites, and is expected to lift recurring revenues, with Iridium generating ~$883M–$916M in annual sales and ~$483M–$500M EBITDA. Management indicates an improved valuation and faster path to positive free cash flow/EBITDA, which should be a meaningful positive catalyst for RKLB shares and the space connectivity segment.

Analysis

This is less a simple M&A print than a forced re-rating event: RKLB is trying to buy a cash-generating connectivity layer that can subsidize its launch backlog and reduce the “project company” discount. If execution holds, the market should start valuing the business on recurring EBITDA and contracted cash flow rather than distant launch optionality, which is the real driver of multiple expansion.

The competitive read-through is more interesting than the headline. A vertically integrated launch-plus-network platform improves RKLB’s bargaining power with government and enterprise customers, and it raises the bar for smaller satellite operators that lack launch access, spectrum, and subscriber economics in one package. The biggest second-order loser is probably any stand-alone LEO connectivity story that still needs outside launch and spectrum partners; ASTS/GSAT become easier to benchmark against a full-stack incumbent rather than an aspirational network builder.

The market should not assume this is immediately accretive. The first 30-90 days are about financing terms, leverage, and integration credibility; if the consideration is meaningfully stock-heavy, RKLB’s near-term upside is capped by dilution risk even if the strategic logic is sound. The 6-18 month thesis only works if management can keep maintenance capex and churn under control while proving cross-sell and launch synergies; if combined leverage or interest expense forces guidance resets, the “quality” multiple compresses fast. The consensus may be underestimating how much telecom-style capex discipline this business will need, even with better revenue visibility.

Key Decisions for Investors

• Buy RKLB on any post-announcement pullback only after financing terms are disclosed and the market has a clear view on dilution/leverage; upside is best over 3-6 months if the combined entity can prove recurring FCF, but the trade should be cut if pro forma net leverage trends above ~4x or the company revises synergy timing.
• If the deal is stock-heavy, consider a merger-arb style pair: long IRIDQ / short RKLB into the spread, with the thesis that near-term execution risk and dilution cap RKLB while the target should trade toward deal value as approvals progress over 1-3 months.
• Use ASTS/GSAT as a relative-value hedge basket against the vertical-integration story: short 1-3 month call spreads or a small short basket if the market starts pricing RKLB as a full-stack connectivity incumbent; thesis breaks if ASTS wins a new strategic partnership or GSAT shows materially better subscriber retention.
• Watch the first financing and analyst-model revisions as the key catalyst window; if street EBITDA estimates rise but FCF does not, fade the move, because the market will eventually penalize capital intensity more than it rewards headline revenue scale.